Happy 2024! The entire Saul Ewing Health Law Practice Group wishes you and yours a healthy and prosperous new year and successful (and compliant) activities in the health care delivery system this year and beyond....more
2/2/2024
/ Ambulatory Surgery Centers ,
Artificial Intelligence ,
Assisted Living Facilities (ALFs) ,
Centers for Medicare & Medicaid Services (CMS) ,
Controlled Substances Act ,
Department of Health and Human Services (HHS) ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare Facilities ,
HIPAA Violations ,
Hospitals ,
Information Technology ,
Marijuana ,
Medicare ,
Nursing Homes ,
OCR ,
Patient Privacy Rights ,
Pharmaceutical Patents ,
Popular ,
Price Transparency ,
Private Equity ,
Telehealth
See below the Saul Ewing LLP Health Law Practice Group 2023 predictions from various members of our practice group! Our colleagues help interested parties in the health care delivery system with transactional, regulatory,...more
2/23/2023
/ Antitrust Provisions ,
Centers for Medicare & Medicaid Services (CMS) ,
Data Privacy ,
Department of Health and Human Services (HHS) ,
Federal Trade Commission (FTC) ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare Facilities ,
Hospital Mergers ,
Hospitals ,
Pharmaceutical Industry ,
Popular ,
Surprise Medical Bills
The DOJ has concluded that two medical schools had no lawful basis for excluding applicants who had active cases of Hepatitis B because they could not show that these individuals posed a direct threat to the health and safety...more